Pavia, Italy

Paolo Giunchedi


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Paolo Giunchedi: Innovator in Pharmaceutical Compositions

Introduction

Paolo Giunchedi is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 3 patents. His work focuses on enhancing the delivery and effectiveness of active substances in medications.

Latest Patents

One of his latest patents is a process for preparing pharmaceutical compositions that have an increased efficacy. This process involves co-grinding or dry mixing the active substance with cyclodextrins or hydrophilic polymer materials that swell upon contact with water. The result is homogeneous compositions that allow for the rapid release of the active substance into an aqueous medium. Another significant patent involves multilayered controlled-release oral solid pharmaceutical forms, which further exemplifies his innovative approach to drug formulation.

Career Highlights

Throughout his career, Paolo Giunchedi has worked with various companies, including Jagotec AG and Apr Applied Pharma Research SA. His expertise in pharmaceutical sciences has allowed him to develop advanced formulations that improve patient outcomes.

Collaborations

He has collaborated with notable professionals in the field, including Ubaldo Conte and Aldo La Manna. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Paolo Giunchedi's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in pharmaceutical compositions, making him a valuable figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…